[go: up one dir, main page]

NO974994L - Esters of carbapenems - Google Patents

Esters of carbapenems

Info

Publication number
NO974994L
NO974994L NO974994A NO974994A NO974994L NO 974994 L NO974994 L NO 974994L NO 974994 A NO974994 A NO 974994A NO 974994 A NO974994 A NO 974994A NO 974994 L NO974994 L NO 974994L
Authority
NO
Norway
Prior art keywords
carbapenems
esters
methyl
compound
isobutyryloxymethyl
Prior art date
Application number
NO974994A
Other languages
Norwegian (no)
Other versions
NO974994D0 (en
Inventor
George Burton
Stephen Frederick Moss
Alfred John Eglington
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9508955.3A external-priority patent/GB9508955D0/en
Priority claimed from GBGB9508957.9A external-priority patent/GB9508957D0/en
Priority claimed from GBGB9508956.1A external-priority patent/GB9508956D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO974994D0 publication Critical patent/NO974994D0/en
Publication of NO974994L publication Critical patent/NO974994L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det er beskrevet en forbindelse av formel (1) hvor R er valgt fra gruppen bestående av isobutyryloksymetyl, (5-metyl-2-okso-l,3-dioksolen-4-yI)metyl og benzoyloksymetyl. Forbindelsen er nyttig ved behandling av bakierielle infeksjoner.A compound of formula (1) is disclosed wherein R is selected from the group consisting of isobutyryloxymethyl, (5-methyl-2-oxo-1,3-dioxol-4-yl) methyl and benzoyloxymethyl. The compound is useful in the treatment of bacterial infections.

NO974994A 1995-05-03 1997-10-30 Esters of carbapenems NO974994L (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9508955.3A GB9508955D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508957.9A GB9508957D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508956.1A GB9508956D0 (en) 1995-05-03 1995-05-03 Novel compounds
PCT/EP1996/001880 WO1996034868A1 (en) 1995-05-03 1996-05-02 Esters of carbapenems

Publications (2)

Publication Number Publication Date
NO974994D0 NO974994D0 (en) 1997-10-30
NO974994L true NO974994L (en) 1997-10-30

Family

ID=27267696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974994A NO974994L (en) 1995-05-03 1997-10-30 Esters of carbapenems

Country Status (22)

Country Link
EP (1) EP0823910A1 (en)
JP (1) JPH11504910A (en)
KR (1) KR19990008355A (en)
CN (1) CN1185783A (en)
AR (1) AR005416A1 (en)
AU (1) AU5813996A (en)
BG (1) BG102014A (en)
BR (1) BR9608313A (en)
CA (1) CA2217990A1 (en)
CZ (1) CZ347597A3 (en)
EA (1) EA199700293A1 (en)
HU (1) HUP9801066A3 (en)
IL (1) IL118092A0 (en)
MA (1) MA23853A1 (en)
MX (1) MX9708421A (en)
NO (1) NO974994L (en)
OA (1) OA10632A (en)
PE (1) PE50697A1 (en)
PL (1) PL323141A1 (en)
SK (1) SK146497A3 (en)
TR (1) TR199701286T1 (en)
WO (1) WO1996034868A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2902659A1 (en) 2006-06-23 2007-12-28 Pierre Fabre Medicament Sa DHA ESTER AND ITS USE IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES
WO2013157583A1 (en) * 2012-04-18 2013-10-24 大日本住友製薬株式会社 Novel carbapenem compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
CA1212105A (en) * 1980-04-30 1986-09-30 Shoji Ikeda Ampicillin esters and production thereof
WO1995005380A1 (en) * 1993-08-18 1995-02-23 Sankyo Company, Limited Crystalline carbapenem derivatives
ES2188621T3 (en) * 1993-10-29 2003-07-01 Smithkline Beecham Plc DERIVATIVES OF 2- (PIRAZOL-3-IL) CARBAPENEM.

Also Published As

Publication number Publication date
CA2217990A1 (en) 1996-11-07
AU5813996A (en) 1996-11-21
EP0823910A1 (en) 1998-02-18
IL118092A0 (en) 1996-09-12
HUP9801066A3 (en) 1999-01-28
MX9708421A (en) 1998-02-28
BG102014A (en) 1998-11-30
WO1996034868A1 (en) 1996-11-07
MA23853A1 (en) 1996-12-31
BR9608313A (en) 1999-01-26
NO974994D0 (en) 1997-10-30
OA10632A (en) 2002-09-16
KR19990008355A (en) 1999-01-25
PL323141A1 (en) 1998-03-16
CN1185783A (en) 1998-06-24
TR199701286T1 (en) 1998-02-21
PE50697A1 (en) 1997-12-18
CZ347597A3 (en) 1998-08-12
AR005416A1 (en) 1999-06-23
HUP9801066A2 (en) 1998-08-28
JPH11504910A (en) 1999-05-11
EA199700293A1 (en) 1998-06-25
SK146497A3 (en) 1998-05-06

Similar Documents

Publication Publication Date Title
CA2147753A1 (en) Tropone-substituted phenyloxazolidinone antibacterial agents
NO996108L (en) 9 oksinerytromycinderivater
CA2028163A1 (en) Solid antimicrobial
PH30007A (en) 7-(Substituted)-9-¬(sub-stituted glycyl)amido¾-6-dimethyl-6-deoxytetra-cyclines
IL190780A0 (en) Heterocyclic substituted aminoazacycles useful as central nervous system agents
MX9803650A (en) Benzoxazine antimicrobial agents.
IL97344A0 (en) Compositions for treating infections caused by organisms sensitive to beta-lactam antibiotics
AU4454597A (en) Novel benzofuran-4-carboxamides
AU4652000A (en) Fab i inhibitors
PL358666A1 (en) 2-hydroxy-mutilin carbamate derivatives for antibacterial use
NZ308518A (en) Antibacterial cephalosporins
UA27910C2 (en) Method of increasing thrombomodulin expression and increasing protein c activation rate
CA2267309A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
MX9708611A (en) Dialkyltiacumicin compounds.
AU3515193A (en) Antimicrobial carbapenem derivatives, their preparation and their therapeutic use
AU2713897A (en) Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
NO974994L (en) Esters of carbapenems
CA2144344A1 (en) Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents
IE792462L (en) Azetidinones.
ATE160357T1 (en) NEW ANTIBIOTIC, DEOXYMULÜNDOCANDIN, METHOD FOR ITS PRODUCTION AND USE AS A MEDICATION
PT713702E (en) ANSIOLITIC AGENT
MY117563A (en) Tropone-substituted phenyloxazolidinone antibacterial
MX9605773A (en) Cephalosporin compounds and processes for the preparation thereof.
NO974870L (en) Newly substituted tetrahydropyrano-3,2-d
HK1037637A (en) Treatment of bacterial infections

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application